ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,063Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 457

$2.14M Total Retail Price of All Prescriptions

Rank: 6 out of 457

456 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 456 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

3% of this provider’s 29,392 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

39% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

68 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
CRESTOR 1,204 1,107 1 9
IBUPROFEN 895 831 2 14
OMEPRAZOLE 878 835 3 1
AMLODIPINE BESYLATE 772 701 4 4
NEXIUM 751 694 5 12
HYDROCHLOROTHIAZIDE 662 623 6 8
LISINOPRIL 635 615 7 3
DONEPEZIL HCL 625 615 8 22
LIDODERM 597 580 9 31
ADVAIR DISKUS 539 501 10 27
CLOPIDOGREL 479 465 11 19
ENALAPRIL MALEATE 476 427 12 35
SINGULAIR 474 445 13 43
METOPROLOL SUCCINATE 450 431 14 21
PROAIR HFA 441 411 15 66
RANITIDINE HCL 429 403 16 17
ZOLPIDEM TARTRATE 423 404 17 13
FUROSEMIDE 412 390 18 10
VOLTAREN 394 376 19 34
LOSARTAN POTASSIUM 393 375 20 18
METFORMIN HCL 385 372 21 6
PLAVIX 371 355 22 24
METOPROLOL TARTRATE 348 344 23 7
LEVOTHYROXINE SODIUM 324 307 24 5
FLUTICASONE PROPIONATE 310 291 25 40
MECLIZINE HCL 306 291 26 55
NAMENDA 304 304 27 32
FENOFIBRATE 304 288 27 46
MEGESTROL ACETATE 293 287 R 29 94
DIOVAN 287 277 30 30
CARVEDILOL 277 257 31 20
FLOVENT HFA 276 276 10 32 248
LOVASTATIN 269 269 33 25
DICLOFENAC SODIUM 255 254 34 49
FAMOTIDINE 252 243 35 62
ZETIA 248 224 36 137
SIMVASTATIN 245 230 37 2
TRAMADOL HCL 237 222 38 26
ESCITALOPRAM OXALATE 236 229 39 61
GABAPENTIN 236 234 39 15
CILOSTAZOL 231 219 41 88
MONTELUKAST SODIUM 226 215 42 86
LOVAZA 221 207 43 50
ATENOLOL 214 207 44 11
CLOTRIMAZOLE-BETAMETHASONE 213 210 45 60
GLIMEPIRIDE 207 166 46 75
LACTULOSE 207 192 46 78
PRAVASTATIN SODIUM 206 204 48 29
PENTOXIFYLLINE 204 198 49 67
DEXILANT 178 178 50 118
GLYBURIDE-METFORMIN HCL 176 164 R 51 70
ATORVASTATIN CALCIUM 174 154 52 33
CELEBREX 173 167 53 53
NASONEX 173 161 53 129
ISOSORBIDE MONONITRATE ER 164 158 55 84
AMLODIPINE BESYLATE-BENAZEPRIL 162 136 56 72
METOCLOPRAMIDE HCL 158 145 57 116
NAPROXEN 155 155 58 65
POTASSIUM CHLORIDE 150 146 59 28
TRICOR 148 112 60 83
CITALOPRAM HBR 147 145 61 45
CLOTRIMAZOLE 144 142 62 207
ALENDRONATE SODIUM 143 142 63 16
DIGOXIN 142 140 64 69
BYSTOLIC 142 142 64 122
PAROXETINE HCL 138 117 66 68
LYRICA 136 123 67 77
SPIRIVA 135 133 68 101
TAMSULOSIN HCL 132 132 69 36
JANUVIA 131 127 70 80
INSULIN SYRINGE 123 118 71 79
CYCLOBENZAPRINE HCL 120 97 R 72 99
COMBIVENT 119 119 73 133
TRAMADOL HCL-ACETAMINOPHEN 119 115 73 134
AMMONIUM LACTATE 119 108 73 82
DIOVAN HCT 118 118 76 51
FEXOFENADINE HCL 117 108 77 269
SYMBICORT 115 115 78 106
LANSOPRAZOLE 112 101 79 74
LEXAPRO 111 108 80 138
CIPROFLOXACIN HCL 109 103 81 71
MUPIROCIN 109 98 81 91
METFORMIN HCL ER 107 107 83 143
MIRTAZAPINE 106 106 84 100
ONGLYZA 101 88 85 140
VENTOLIN HFA 96 94 86 96
KETOCONAZOLE 95 88 87 92
LANTUS 90 90 88 56
BETAMETHASONE DIPROPIONATE 88 88 89 223
AVODART 86 86 90 110
CLOBETASOL PROPIONATE 86 78 90 125
CREON 85 83 92 209
DESONIDE 83 80 93 331
DILTIAZEM 24HR CD 83 83 93 232
NITROSTAT 81 78 95 167
ACTOS 80 80 96 105
LISINOPRIL-HYDROCHLOROTHIAZIDE 79 68 97 37
DOXAZOSIN MESYLATE 77 77 98 73
AZITHROMYCIN 77 74 98 44
BENAZEPRIL HCL 76 70 100 114
SILVER SULFADIAZINE 75 66 101 127
SURE COMFORT 74 74 102 103
MELOXICAM 74 71 102 41
SERTRALINE HCL 73 73 104 57
DICYCLOMINE HCL 72 65 105 115
VESICARE 70 70 106 173
JANUMET 68 58 107 154
NOVOLIN 70-30 66 62 108 113
LOSARTAN-HYDROCHLOROTHIAZIDE 66 54 108 54
NOVOLOG 65 65 110 181
FINASTERIDE 63 63 111 85
NIFEDIPINE ER 63 60 111 89
VERAPAMIL ER 63 63 111 145
PROPRANOLOL HCL 61 47 114 176
PROCTOZONE-HC 58 58 115 193
SEROQUEL XR 58 50 115 168
GLIPIZIDE XL 57 57 117 159
BONIVA 56 41 118 206
NITROGLYCERIN PATCH 54 54 119 157
SUCRALFATE 54 54 119 163
BUMETANIDE 53 53 121 123
GLIPIZIDE ER 52 52 122 107
IBANDRONATE SODIUM 52 52 122 183
OXYBUTYNIN CHLORIDE 52 52 122 142
DICLOFENAC POTASSIUM 51 50 125 164
TRIAMTERENE-HCTZ 50 50 126 120
ACETAMINOPHEN-CODEINE 50 34 S3 126 192
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 27, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.